Skip to Main Content

WASHINGTON — Supreme Court justices on Tuesday seemed to question physicians’ right to sue the Food and Drug Administration to reinstate restrictions around a commonly used abortion pill — a line of questioning that suggests they are unlikely to restrict access to the pill.

Justices Elena Kagan and Ketanji Brown Jackson, in particular, repeatedly asked the plaintiffs, a Christian-based medical organization, for examples of when objecting physicians were forced to assist with abortion or its complications as a direct result of the FDA relaxing restrictions around mifepristone prescribing. Conservative Justice Samuel Alito, while appearing more sympathetic to the plaintiffs than others, also asked the lawyer representing the agency whether the scenario — a morally opposed doctor forced to treat a patient who had taken mifepristone — was “too speculative.”

advertisement

Justice Neil Gorsuch, a Trump appointee, interjected at one point to vent about the “rash” of injunctions lower courts have imposed over the past several years, seemingly lobbing a complaint at Texas Judge Matthew Kacsmaryk, who first heard the case and ordered mifepristone off the market. An appeals court later reversed that ruling but upheld injunctions against two FDA decisions that extended mifepristone use to 10 weeks of pregnancy from seven, and removed the in-person dispensing requirement, which opened the channels for mail orders of the drug.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.